⌘K

Login Start Free

Home/Filings/4/0001104659-23-126369

4//SEC Filing

MONAHAN JOHN J 4

Accession 0001104659-23-126369

CIK 0000894158other

View on SEC.gov Company Profile

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 4:00 PM ET

Size

5.6 KB

Accession

0001104659-23-126369

Insider Transaction Report

Form 4

Period: 2023-12-14

Theriva Biologics, Inc.TOVX

Director

Transactions

Award
Stock Options (right to buy)
2023-12-14+110,000→ 110,000 total
Exercise: $0.59From: 2024-01-14Exp: 2030-12-14→ Common Stock (110,000 underlying)

Footnotes (1)

[F1]These stock options vest pro rata on a monthly basis over 12 months.

Documents

1 file

4
tm2332964-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Theriva Biologics, Inc.

CIK 0000894158

Entity typeother

Related Parties

1

filerCIK 0001257825

Filing Metadata

Form type: 4
Filed: Dec 14, 7:00 PM ET
Accepted: Dec 15, 4:00 PM ET
Size: 5.6 KB

View on SEC.gov